Definition of the human immunodeficiency virus type 1 Rev and human T-cell leukemia virus type I Rex protein activation domain by functional exchange. 1992

I Weichselbraun, and G K Farrington, and J R Rusche, and E Böhnlein, and J Hauber
SANDOZ Research Institute, Vienna, Austria.

The human retroviruses human immunodeficiency virus type 1 (HIV-1) and human T-cell leukemia virus type I (HTLV-I) are characterized by complex regulation of gene expression. Each virus encodes a posttranscriptional regulator, the 19-kDa HIV-1 Rev protein and the 27-kDa HTLV-I Rex protein, which is required for viral replication. Expression of these trans activators results in the cytoplasmic accumulation of unspliced or singly spliced viral mRNA which encode the gag, pol, and env gene products. The finding that the HTLV-I Rex protein is able to functionally substitute for the Rev protein of HIV-1 indicates that HIV-1 Rev and HTLV-I Rex may interact with the same component of a cellular pathway involved in either mRNA splicing or transport. In this study, we have generated functional Rev/Rex hybrid proteins by domain exchange. We have defined, using in vivo and in vitro analyses, the activation domains of Rev and Rex which are the putative targets of a common host cell factor(s) required for Rev and Rex function.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D011993 Recombinant Fusion Proteins Recombinant proteins produced by the GENETIC TRANSLATION of fused genes formed by the combination of NUCLEIC ACID REGULATORY SEQUENCES of one or more genes with the protein coding sequences of one or more genes. Fusion Proteins, Recombinant,Recombinant Chimeric Protein,Recombinant Fusion Protein,Recombinant Hybrid Protein,Chimeric Proteins, Recombinant,Hybrid Proteins, Recombinant,Recombinant Chimeric Proteins,Recombinant Hybrid Proteins,Chimeric Protein, Recombinant,Fusion Protein, Recombinant,Hybrid Protein, Recombinant,Protein, Recombinant Chimeric,Protein, Recombinant Fusion,Protein, Recombinant Hybrid,Proteins, Recombinant Chimeric,Proteins, Recombinant Fusion,Proteins, Recombinant Hybrid
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D015368 Human T-lymphotropic virus 1 A strain of PRIMATE T-LYMPHOTROPIC VIRUS 1 isolated from mature T4 cells in patients with T-lymphoproliferation malignancies. It causes adult T-cell leukemia (LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED), T-cell lymphoma (LYMPHOMA, T-CELL), and is involved in mycosis fungoides, SEZARY SYNDROME and tropical spastic paraparesis (PARAPARESIS, TROPICAL SPASTIC). ATLV,Adult T-Cell Leukemia-Lymphoma Virus I,HTLV-1,HTLV-I,Human T-Cell Leukemia Virus I,Leukemia Virus I, Human T-Cell,T-Cell Leukemia Virus I, Human,Adult T Cell Leukemia Lymphoma Virus I,Human T Cell Leukemia Virus I,Leukemia Lymphoma Virus I, Adult T Cell,Leukemia Virus I, Human T Cell,T Cell Leukemia Virus I, Human,Human T lymphotropic virus 1
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015533 Transcriptional Activation Processes that stimulate the GENETIC TRANSCRIPTION of a gene or set of genes. Gene Activation,Genetic Induction,Transactivation,Induction, Genetic,Trans-Activation, Genetic,Transcription Activation,Activation, Gene,Activation, Transcription,Activation, Transcriptional,Genetic Trans-Activation,Trans Activation, Genetic
D015694 Gene Products, rev Trans-acting nuclear proteins whose functional expression are required for retroviral replication. Specifically, the rev gene products are required for processing and translation of the gag and env mRNAs, and thus rev regulates the expression of the viral structural proteins. rev can also regulate viral regulatory proteins. A cis-acting antirepression sequence (CAR) in env, also known as the rev-responsive element (RRE), is responsive to the rev gene product. Rev is short for regulator of virion. rev Gene Products,rev Protein,Gene Product, rev,rev Gene Product
D016370 Gene Products, rex Post-transcriptional regulatory proteins required for the accumulation of mRNAs that encode the gag and env gene products in HUMAN T-LYMPHOTROPIC VIRUS 1 and HUMAN T-LYMPHOTROPIC VIRUS 2. The rex (regulator x; x is undefined) products act by binding to elements in the LONG TERMINAL REPEAT. p27(rex),rex Gene Products,rex Protein,Gene Product, rex,p27 rex,rex Gene Product
D054321 rev Gene Products, Human Immunodeficiency Virus Proteins encoded by the REV GENES of the HUMAN IMMUNODEFICIENCY VIRUS. HIV rev Gene Product,Trans-Activator Protein, HIV,art-trs Gene Protein, HIV,trs-art Gene Protein, HIV,HIV art-trs Gene Protein,HIV trs-art Gene Protein,Transactivator Protein, HIV,HIV Trans-Activator Protein,HIV Transactivator Protein,HIV art trs Gene Protein,HIV trs art Gene Protein,Trans Activator Protein, HIV,art trs Gene Protein, HIV,trs art Gene Protein, HIV

Related Publications

I Weichselbraun, and G K Farrington, and J R Rusche, and E Böhnlein, and J Hauber
January 1991, Journal of virology,
I Weichselbraun, and G K Farrington, and J R Rusche, and E Böhnlein, and J Hauber
September 1993, Journal of virology,
I Weichselbraun, and G K Farrington, and J R Rusche, and E Böhnlein, and J Hauber
August 1991, Journal of virology,
I Weichselbraun, and G K Farrington, and J R Rusche, and E Böhnlein, and J Hauber
July 1991, Proceedings of the National Academy of Sciences of the United States of America,
I Weichselbraun, and G K Farrington, and J R Rusche, and E Böhnlein, and J Hauber
May 1991, Journal of virology,
I Weichselbraun, and G K Farrington, and J R Rusche, and E Böhnlein, and J Hauber
December 1992, Journal of virology,
I Weichselbraun, and G K Farrington, and J R Rusche, and E Böhnlein, and J Hauber
May 1993, Journal of virology,
I Weichselbraun, and G K Farrington, and J R Rusche, and E Böhnlein, and J Hauber
December 2003, Journal of virology,
I Weichselbraun, and G K Farrington, and J R Rusche, and E Böhnlein, and J Hauber
December 1991, Journal of virology,
I Weichselbraun, and G K Farrington, and J R Rusche, and E Böhnlein, and J Hauber
November 1991, Journal of virology,
Copied contents to your clipboard!